MedPath

Multicenter pilot study to determine the feasibility of a multimodal prehabilitation program in patients with non-small cell lung cancer undergoing anatomical lung resectio

Completed
Conditions
10029107
Non-small cell lung carcinoma
lung cancer
10038666
Registration Number
NL-OMON48205
Lead Sponsor
Maxima Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

- *18 years of age
- NSCLC, pathologically confirmed or high clinical suspicion
- Eligible for anatomical lung resection, that will be performed in MMC or ASz
- Straight forward preoperative work-up, with confirmation of eligibility for
surgery by lung surgeon before the multidisciplinary team meeting
- Written informed consent

Exclusion Criteria

- Inability to give written informed consent (illiteracy, language barrier,
cognitive disabilities)
- Contra-indication for training (e.g. comorbid conditions, signs of
undiagnosed cardiac disease, physical or psychological impairments)
- Renal insufficiency, defined as estimated Glomerular Filtration Rate (eGFR)
<60 ml/min/1.73m2 (estimated using the Modification of Diet in Renal Disease
(MDRD) formula in the MMC and estimated using the Chronic Kidney Disease
Epidemiology Collaboration (CKD-EPI) formula in the ASz)
- Participation in MEDIAST trial (NTR6528; NL60692.015.17)
- In case of patients in ASz: referral by pulmonologist from Beatrix hospital,
Gorinchem (the Netherlands) for surgery in ASz

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath